1 completed, 1 not yet recruiting, 1 withdrawn. 2 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Not yet recruiting 1, Withdrawn 1 |
| Not applicable | 1 | Completed 1 |
Follow Facial Hyperpigmentation: new trials by email Literature Review of Facial Hyperpigmentation trials Research Report on Facial Hyperpigmentation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Topical Metformin Versus Triple Regimen for Epidermal Melasma Topical 30% metformin cream, Topical Triple Regimen - Epidermal Melasma, Facial Hyperpigmentation | Phase 2 | Not yet recruiting | Combined Military Hospital, Pakistan | 104 | 2026-08-15 | 2026-08-21 |
| Open-label, Single-arm, Proof of Concept Study in Subjects with Mild-to-moderate Facial Hyperpigmentation Test cosmetic product - Facial Hyperpigmentation | Phase 2 | Withdrawn | Kayuraeffect, LLP | 2025-01-01 | 2024-12-16 | |
| Efficacy and Tolerability of an Isobutylamido-thiazolyl-resorcinol Cream 0.2% for Facial Hyperpigmentation Isobutylamido-thiazolyl-resorcinol Cream 0.2%, Vehicle - Facial Hyperpigmentation | Not applicable | Completed | Institute of Dermatology, Thailand | 200 | 2019-04-29 | 2022-04-06 |
Melanosis (2) · Hyperpigmentation (1) · Skin Diseases (1)
Pigmentation Disorders (2) · Skin and Connective Tissue Diseases (2) · Hyperpigmentation (1) · Skin Diseases (1)
Combined Military Hospital, Pakistan (1) · Institute of Dermatology, Thailand (1) · Kayuraeffect, LLP (1)
Pakistan (1) · Thailand (1) · United States (1)
Chinmanat Lekhavat, MD (1) · Dr. Prayag Shah, MD, MBA (1)